Home LiteratureArticle Details
PMID: 760802 Published · ppublish English Comparative Study Journal Article

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.

Biochimica et biophysica acta ·Vol. 576 ·No. 1 ·1979-01-25 ·Pages 151-62

Arlaud GJ, Reboul A, Sim RB, Colomb MG

Abstract

1. Insoluble IgG-ovalbumin aggregates were used to bind and activate C1 from human serum. The bound C1 provided a useful reagent for studying the interaction of C1 subcomponents with C1-inhibitor. 2. C1-inhibitor bound to both subcomponents (C1r and C1s in C1 and formed stable complexes of respective apparent molecular weights 197,000 and 185,000, as determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. The binding reaction proceeded more readily with C1s than with C1r and was correlated with the inhibition of C1s esterase activity. 3. At physiological ionic strength, binding of C1-inhibitor to subcomponents C1r and C1s caused release of these subcomponents from the C1-immune aggregates complex, indicating that C1-inhibitor binding decreased the inter-subcomponent binding forces in C1. At low ionic strength, however, this release did not occur.

MeSH Terms
Complement C1 Complement C1 Inactivator Proteins Humans Immunoglobulin G Kinetics Macromolecular Substances Ovalbumin Protein Binding
Chemicals
Complement C1 Complement C1 Inactivator Proteins Immunoglobulin G Macromolecular Substances Ovalbumin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Arlaud G J
Reboul A
Sim R B
Colomb M G
Article Info
Journal
Biochimica et biophysica acta
Abbr.
Biochim Biophys Acta
ISSN
0006-3002
Published
1979-01-25
Pages
151-62
Language
English
Region
Netherlands
NLM ID
0217513
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]